Let’s hope it doesn’t happen, but if a mass explosion of coronavirus is upon us, it will be because of the Indian government’s refusal to test a large number of suspected patients.
Private facilities are not allowed to test for COVID-19 now. But if number of suspected cases in India increases, government resources won’t be enough.
Like China, India remains a big domestic market, which will continue to attract investment, but the US tariffs will make India unattractive for future investments.
New bill aims to fix key issues with IBC 2016, including delays & patchy implementation, and protect creditors, with window for genuine promoters to retain control of their companies.
India’s 1st tri-service seminar, on the lines of Shangri-La Dialogue, kicks off in Mhow, with top military officers & defence attaches from several countries in attendance.
Putin sees this as a victory. Europeans have decided to deal with Trump on his terms for the sake of the larger Western alliance. We look at the lessons for us in India.
. When India is the highest producer of HCQ tablets and having the capacity to produce and meet up the demands of the rest of the world, I think it’s an opportunity for India to extend it’s helping hand to the suffering world to save lives .Once again India will emerge as the Saver of Mankind and as the VISHWA GURU .
The first wholly Indian company that started producing this and other drugs effective against malaria and many tropical diseases was the Bengal Chemicals & Pharmaceuticals established in 1901 by the legendary Dr. P.C. Ray. As it happens this national asset was nationalsed by the Govenment of India, was deliberately mismanaged to make it unprofitable and sick and then has been put on the block for selling off. Its vast manufacturing facility at Kolkata is planned to be sold off to real estate developers! This company still manufactures hydroxychloroquine, but the government does not want to use its capabilities even in this national health emergency.
Jab Hamare pass phle se Hi Kafi tablet Hai or India is leading producer in world and can produce 20 crore pills per month ….
To Kisi Ki help Karne me kya Burai Hai ..
Hame Ishwar Ne Kisi Ki help karne ke liye kabil samjha achi hai.
That explains why IPCA labs share price was rocketing even before the news came out. too.
I presumed because they were the main manufacturers of Chloroquine but not that they got the order from INdian government
West Bengal to procure 3 million tablets to tackle corona
TNN | Apr 8, 2020, 06:11 IST
TNN
Representative image
KOLKATA: The state government is going to procure 3 million hydroxychloroquine tablets and has already placed orders for it, a senior Nabanna official said on Monday. “We are expecting the supply in phases before the lockdown period is over,” the official said.
The health official said Bengal had already purchased 4.5 lakh hydroxychloroquine tablets, part of which was distributed in various malaria clinics in Kolkata and the districts. A fresh stock-taking exercise is being conducted on unused hydroxychloroquine tablets. “We have sufficient stock for now,” said the official.
READ MORE FROM TOI+
TOI profiles Edgar Julian Remedios, one of the seven Covid-19 cases in Goa who are undergoing treatment
Sukumar Mukherjee, who heads the expert committee on Covid-19, said hydroxychloroquine, which is considered as a prophylactic for front-line medical staffers and preliminary responders, can also be used to treat patients. Mukherjee indicated these can also be used to treat suspected Covid-19 cases who have been quarantined.
An official said they had already contacted Kolkata-based PSU Bengal Chemicals for the drug. “They informed that it was not within their capacity to supply the entire amount due to lack of raw materials,” the officer claimed. “Meetings have also been held with Wallace Pharma and IPCA Laboratories but they said they had problems in bulk production due to the lockdown,” he added.
newsletter
According to Raju Khandelwal of the Indian Pharmaceutical Association, the health ministry has recently made the drug a Schedule H1 category drug, which means it cannot be sold over the counter without prescription, to stop hoarding. Moreover, Khandelwal said the cost of raw material that is sourced from China had more than doubled, for which there is a shortage.
ICMR has recommended the drug for healthcare workers involved in treatment of suspected or active Covid-19 patients, a health official said. According to reports, there is a rush among people to buy the drug, which is mainly used in malaria and in some cases of rheumatoid arthritis and autoimmune disease, doctors said.
Santanu Sen, Trinamool MP and former Indian Medical Association president, wants the drug to be only be used by health workers and suspected cases of Covid-19. “There is a specific dose of the drug for health workers who are being directly exposed to the virus. For them, it is to be continued for seven weeks. For those who are in indirect contact, it is to be taken for three weeks,” he said.
It’s very sad that India’s oldest manufacturer of Hydroxychloroquine ( HCQ) and pioneer in this field ‘ BENGAL CHEMICALS’ disndi get the order!
Could you order for any other phama company. Only two company in india .
We are interested to buy from BCPL, if they have availability of HCQ of any quantity per day basis.
. When India is the highest producer of HCQ tablets and having the capacity to produce and meet up the demands of the rest of the world, I think it’s an opportunity for India to extend it’s helping hand to the suffering world to save lives .Once again India will emerge as the Saver of Mankind and as the VISHWA GURU .
Azithromycin tablets can be given for one week to minimize any manifestation of ailments caused by virus,
The first wholly Indian company that started producing this and other drugs effective against malaria and many tropical diseases was the Bengal Chemicals & Pharmaceuticals established in 1901 by the legendary Dr. P.C. Ray. As it happens this national asset was nationalsed by the Govenment of India, was deliberately mismanaged to make it unprofitable and sick and then has been put on the block for selling off. Its vast manufacturing facility at Kolkata is planned to be sold off to real estate developers! This company still manufactures hydroxychloroquine, but the government does not want to use its capabilities even in this national health emergency.
I totally agree with you Sir
Jab Hamare pass phle se Hi Kafi tablet Hai or India is leading producer in world and can produce 20 crore pills per month ….
To Kisi Ki help Karne me kya Burai Hai ..
Hame Ishwar Ne Kisi Ki help karne ke liye kabil samjha achi hai.
Send tablets to hotspots to prevent further infection. Why govt delaying. Maharastra and tamilnadu are in hotspots.
India shining without Congress! Ha,Ha,Ha
Idiot dont talk politics when people are dieing..
That explains why IPCA labs share price was rocketing even before the news came out. too.
I presumed because they were the main manufacturers of Chloroquine but not that they got the order from INdian government
West Bengal to procure 3 million tablets to tackle corona
TNN | Apr 8, 2020, 06:11 IST
TNN
Representative image
KOLKATA: The state government is going to procure 3 million hydroxychloroquine tablets and has already placed orders for it, a senior Nabanna official said on Monday. “We are expecting the supply in phases before the lockdown period is over,” the official said.
The health official said Bengal had already purchased 4.5 lakh hydroxychloroquine tablets, part of which was distributed in various malaria clinics in Kolkata and the districts. A fresh stock-taking exercise is being conducted on unused hydroxychloroquine tablets. “We have sufficient stock for now,” said the official.
READ MORE FROM TOI+
TOI profiles Edgar Julian Remedios, one of the seven Covid-19 cases in Goa who are undergoing treatment
Sukumar Mukherjee, who heads the expert committee on Covid-19, said hydroxychloroquine, which is considered as a prophylactic for front-line medical staffers and preliminary responders, can also be used to treat patients. Mukherjee indicated these can also be used to treat suspected Covid-19 cases who have been quarantined.
An official said they had already contacted Kolkata-based PSU Bengal Chemicals for the drug. “They informed that it was not within their capacity to supply the entire amount due to lack of raw materials,” the officer claimed. “Meetings have also been held with Wallace Pharma and IPCA Laboratories but they said they had problems in bulk production due to the lockdown,” he added.
newsletter
According to Raju Khandelwal of the Indian Pharmaceutical Association, the health ministry has recently made the drug a Schedule H1 category drug, which means it cannot be sold over the counter without prescription, to stop hoarding. Moreover, Khandelwal said the cost of raw material that is sourced from China had more than doubled, for which there is a shortage.
ICMR has recommended the drug for healthcare workers involved in treatment of suspected or active Covid-19 patients, a health official said. According to reports, there is a rush among people to buy the drug, which is mainly used in malaria and in some cases of rheumatoid arthritis and autoimmune disease, doctors said.
Santanu Sen, Trinamool MP and former Indian Medical Association president, wants the drug to be only be used by health workers and suspected cases of Covid-19. “There is a specific dose of the drug for health workers who are being directly exposed to the virus. For them, it is to be continued for seven weeks. For those who are in indirect contact, it is to be taken for three weeks,” he said.